Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Contemporary Clinical Trials Communications
|
March 8, 2021
Bayesian optimization for estimating the maximum tolerated dose in Phase I clinical trials
Ami Takahashi, Taiji Suzuki
Pharmaceutical Statistics
|
December 1, 2020
Bayesian optimization design for dose-finding based on toxicity and efficacy outcomes in phase I/II clinical trials
Ami Takahashi, Taiji Suzuki
The International Journal of Biostatistics
|
April 5, 2021
Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials
Ami Takahashi, Taiji Suzuki
Plant Direct
|
May 7, 2025
UV-B Irradiation Does Not Promote Flowering in <i>Arabidopsis</i> Despite Increased <i>FT</i> Expression
Ami Takahashi, Yuki Takahashi, Jun Hidema, et al.
The Journal of Toxicological Sciences
|
May 14, 2013
TO901317, a potent LXR agonist, is an inverse agonist of CAR
Yuichiro Kanno, Nobuaki Tanuma, Ami Takahashi, et al.
International Immunopharmacology
|
July 5, 2017
Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice
Naoyoshi Maeda, Chisato Yamada, Ami Takahashi, et al.
Scientific Reports
|
January 20, 2025
Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
Chisato Yamada, Kimiko Kuroki, Naoyoshi Maeda, et al.
International Journal of Molecular Sciences
|
November 30, 2019
Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward Available Antibodies: Implications of Structural Characteristics of HLA-G Isoforms
Atsushi Furukawa, Manami Meguro, Rika Yamazaki, et al.
International Journal of Clinical Oncology
|
June 30, 2026
A phase 1 dose-finding and pharmacokinetic study of acasunlimab alone or in combination with pembrolizumab in Japanese patients with advanced or metastatic solid tumors
Noboru Yamamoto, Gaurav Bajaj, Homer C Adams, et al.
Journal of Medical Microbiology
|
August 25, 2021
Emergence of a multidrug-resistant plasmid encoding <i>bla</i> <sub>NDM-1</sub>, <i>bla</i> <sub>OXA-420</sub> and <i>armA</i> in a clinical isolate of <i>Acinetobacter variabilis</i> in Japan
Kohei Uechi, Mari Tohya, Tatsuya Tada, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Contemporary Clinical Trials Communications
|
March 8, 2021
Bayesian optimization for estimating the maximum tolerated dose in Phase I clinical trials
Ami Takahashi, Taiji Suzuki
Pharmaceutical Statistics
|
December 1, 2020
Bayesian optimization design for dose-finding based on toxicity and efficacy outcomes in phase I/II clinical trials
Ami Takahashi, Taiji Suzuki
The International Journal of Biostatistics
|
April 5, 2021
Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials
Ami Takahashi, Taiji Suzuki
Plant Direct
|
May 7, 2025
UV-B Irradiation Does Not Promote Flowering in <i>Arabidopsis</i> Despite Increased <i>FT</i> Expression
Ami Takahashi, Yuki Takahashi, Jun Hidema, et al.
The Journal of Toxicological Sciences
|
May 14, 2013
TO901317, a potent LXR agonist, is an inverse agonist of CAR
Yuichiro Kanno, Nobuaki Tanuma, Ami Takahashi, et al.
International Immunopharmacology
|
July 5, 2017
Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice
Naoyoshi Maeda, Chisato Yamada, Ami Takahashi, et al.
Scientific Reports
|
January 20, 2025
Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
Chisato Yamada, Kimiko Kuroki, Naoyoshi Maeda, et al.
International Journal of Molecular Sciences
|
November 30, 2019
Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward Available Antibodies: Implications of Structural Characteristics of HLA-G Isoforms
Atsushi Furukawa, Manami Meguro, Rika Yamazaki, et al.
International Journal of Clinical Oncology
|
June 30, 2026
A phase 1 dose-finding and pharmacokinetic study of acasunlimab alone or in combination with pembrolizumab in Japanese patients with advanced or metastatic solid tumors
Noboru Yamamoto, Gaurav Bajaj, Homer C Adams, et al.
Journal of Medical Microbiology
|
August 25, 2021
Emergence of a multidrug-resistant plasmid encoding <i>bla</i> <sub>NDM-1</sub>, <i>bla</i> <sub>OXA-420</sub> and <i>armA</i> in a clinical isolate of <i>Acinetobacter variabilis</i> in Japan
Kohei Uechi, Mari Tohya, Tatsuya Tada, et al.
Page
of 2